M. Le-mappian, Aspect clinique des états dépressifs. L'Encéphale, p.33, 2007.

J. Delay, G. Roussy, and F. Alcan, Les dérèglements de l'humeur, 1946.

C. L. Bowden, A different depression: clinical distinctions between bipolar and unipolar depression, Journal of affective disorders, vol.84, issue.2-3, pp.117-125, 2005.

J. R. Geddes, S. M. Carney, C. Davies, T. A. Furukawa, D. J. Kupfer et al., Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, The Lancet, vol.361, issue.9358, pp.653-661, 2003.

, Diagnostic and statistical manual of mental health disorders, DSM 5, 2013.

, International Statistical Classification of Diseases and Related Health Problems: tenth revision-Version for, World Health Organization, 2007.

M. Hamilton, A rating scale for depression, Journal of neurology, vol.23, issue.1, p.56, 1960.

S. A. Montgomery and M. A. Åsberg, A new depression scale designed to be sensitive to change, The British journal of psychiatry, vol.134, issue.4, pp.382-389, 1979.

J. P. Lépine, I. Gasquet, V. Kovess, S. Arbabzadeh-bouchez, L. Nègre-pagès et al., Prévalence et comorbidité des troubles psychiatriques dans la population générale française: résultats de l'étude épidémiologique ESEMeD/MHEDEA 2000/(ESEMeD). L'encéphale, vol.31, pp.182-194, 2005.

, The global burden of disease: 2004 update, World Health Organization, 2008.

K. Chevreul, A. Prigent, A. Bourmaud, M. Leboyer, and I. Durand-zaleski, The cost of mental disorders in France, European Neuropsychopharmacology, vol.23, issue.8, pp.879-886, 2013.

L. Andrade, J. J. Caraveo-anduaga, P. Berglund, R. V. Bijl, R. D. Graaf et al., The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys, International journal of methods in psychiatric research, vol.12, issue.1, pp.3-21, 2003.

, INPES, 2005.

A. Boyd, S. Van-de-velde, G. Vilagut, R. De-graaf, S. Florescu et al., Gender differences in mental disorders and suicidality in Europe: results from a large cross-sectional population-based study, Journal of affective disorders, vol.173, pp.245-254, 2015.

E. Chesney, G. M. Goodwin, and S. Fazel, Risks of all-cause and suicide mortality in mental disorders: a meta-review, World Psychiatry, vol.13, issue.2, pp.153-160, 2014.

M. T. Treadway and D. A. Pizzagalli, Imaging the pathophysiology of major depressive disorder-from localist models to circuit-based analysis, Biology of mood & anxiety disorders, vol.4, issue.1, p.5, 2014.

M. Spedding, T. Jay, J. C. Silva, and L. Perret, A pathophysiological paradigm for the therapy of psychiatric disease, Nature Reviews Drug Discovery, vol.4, issue.6, p.467, 2005.

P. , M. F. Lôo, and H. , Facteurs non spécifiques de variations de paramètres biologiques étudiés en psychiatrie biologique. Discussion, Annales médicopsychologiques, vol.150, pp.181-186, 1992.

W. C. Drevets, Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders, Current opinion in neurobiology, vol.11, issue.2, pp.240-249, 2001.

J. J. Schildkraut, The catecholamine hypothesis of affective disorders: a review of supporting evidence, American journal of Psychiatry, vol.122, issue.5, pp.509-522, 1965.

J. Sacher, J. Neumann, T. Fünfstück, A. Soliman, A. Villringer et al., Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder, Journal of affective disorders, vol.140, issue.2, pp.142-148, 2012.

P. Klauser, A. Fornito, V. Lorenzetti, C. G. Davey, D. B. Dwyer et al., Cortico-limbic network abnormalities in individuals with current and past major depressive disorder, Journal of affective disorders, vol.173, pp.45-52, 2015.

W. C. Drevets, J. L. Price, and M. L. Furey, Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain structure and function, vol.213, pp.93-118, 2008.

R. H. Belmaker and G. Agam, Major depressive disorder, New England Journal of Medicine, vol.358, issue.1, pp.55-68, 2008.

V. Krishnan and E. J. Nestler, The molecular neurobiology of depression, Nature, vol.455, issue.7215, p.894, 2008.

A. F. Schatzberg and C. B. Nemeroff, The American psychiatric publishing textbook of psychopharmacology, 2009.

C. Moret and M. Briley, The importance of norepinephrine in depression, Neuropsychiatric disease and treatment, vol.7, p.9, 2011.

V. Maletic, A. Eramo, K. Gwin, S. J. Offord, and R. A. Duffy, The role of norepinephrine and its ?-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: a systematic review, Frontiers in psychiatry, vol.8, p.42, 2017.

B. W. Dunlop and C. B. Nemeroff, The role of dopamine in the pathophysiology of depression, Archives of general psychiatry, vol.64, issue.3, pp.327-337, 2007.

A. A. Grace, Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression, Nature Reviews Neuroscience, vol.17, issue.8, p.524, 2016.

M. S. Lener, M. J. Niciu, E. D. Ballard, M. Park, L. T. Park et al., Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine, Biological psychiatry, vol.81, issue.10, pp.886-897, 2017.

O. A. Petroff, Book review: GABA and glutamate in the human brain, The Neuroscientist, vol.8, issue.6, pp.562-573, 2002.

B. E. Leonard, Psychopathology of depression, Drugs of Today, vol.43, issue.10, pp.705-716, 2007.

K. Hashimoto, Emerging role of glutamate in the pathophysiology of major depressive disorder, Brain research reviews, vol.61, issue.2, pp.105-123, 2009.

G. Sanacora, G. Treccani, and M. Popoli, Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders, Neuropharmacology, vol.62, issue.1, pp.63-77, 2012.

R. Machado-vieira, H. K. Manji, and C. A. Zarate, The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders, The Neuroscientist, vol.15, issue.5, pp.525-539, 2009.

M. J. Niciu, B. Kelmendi, and G. Sanacora, Overview of glutamatergic neurotransmission in the nervous system, Pharmacology Biochemistry and Behavior, vol.100, issue.4, pp.656-664, 2012.

U. Sonnewald and A. Schousboe, Introduction to the glutamate-glutamine cycle, The Glutamate/GABA-Glutamine Cycle, pp.1-7, 2016.

G. Sanacora and M. Banasr, From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders, Biological psychiatry, vol.73, issue.12, pp.1172-1179, 2013.

C. Wu and D. Sun, GABA receptors in brain development, function, and injury. Metabolic brain disease, vol.30, pp.367-379, 2015.

C. F. Sharpley, Malfunction in GABA and glutamate as pathways to depression: a review of the evidence, Clinical Medicine. Therapeutics, vol.1, p.3481, 2009.

J. M. Wiero?ska, A. Pa?ucha-poniewiera, G. Nowak, and A. Pilc, Depression viewed as a GABA/glutamate imbalance in the central nervous system, Clinical, Research and Treatment Approaches to Affective Disorders, 2012.

G. Hasler, Pathophysiology of depression: do we have any solid evidence of interest to clinicians, World Psychiatry, vol.9, issue.3, pp.155-161, 2010.

J. S. Kim, W. Schmid-burgk, D. Claus, and H. H. Kornhuber, Increased serum glutamate in depressed patients, Archiv für Psychiatrie und Nervenkrankheiten, vol.232, issue.4, pp.299-304, 1982.
DOI : 10.1007/bf00345492

C. A. Altamura, M. C. Mauri, A. Ferrara, and A. R. Moro, Plasma and platelet excitatory amino acids in psychiatric disorders, The American journal of psychiatry, vol.150, issue.11, p.1731, 1993.

M. C. Mauri, A. Ferrara, L. Boscati, S. Bravin, F. Zamberlan et al., Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment, Neuropsychobiology, vol.37, issue.3, pp.124-129, 1998.
DOI : 10.1159/000026491

H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C. R. Ashby et al., Correlation between plasma levels of glutamate, alanine and serine with severity of depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.6, pp.1155-1158, 2006.

J. Levine, K. Panchalingam, A. Rapoport, S. Gershon, R. J. Mcclure et al., Increased cerebrospinal fluid glutamine levels in depressed patients, Biological psychiatry, vol.47, issue.7, pp.586-593, 2000.
DOI : 10.1016/s0006-3223(99)00284-x

M. A. Frye, G. E. Tsai, T. Huggins, J. T. Coyle, and R. M. Post, Low cerebrospinal fluid glutamate and glycine in refractory affective disorder, Biological psychiatry, issue.2, pp.162-166, 2007.
DOI : 10.1016/j.biopsych.2006.01.024

S. Holemans, F. De-paermentier, R. W. Horton, M. R. Crompton, C. L. Katona et al., NMDA glutamatergic receptors, labelled with [3H] MK-801, in brain samples from drug-free depressed suicides, Brain research, vol.616, issue.1-2, pp.138-143, 1993.
DOI : 10.1016/0006-8993(93)90202-x

B. I. Gold, M. B. Bowers, R. H. Roth, and D. W. Sweeney, GABA levels in CSF of patients with psychiatric disorders. The American journal of psychiatry, 1980.

F. Petty, G. L. Kramer, C. M. Gullion, and A. J. Rush, Low plasma ?aminobutyric acid levels in male patients with depression, Biological psychiatry, vol.32, issue.4, pp.354-363, 1992.
DOI : 10.1016/0006-3223(92)90039-3

M. Zink, B. Vollmayr, P. J. Gebicke-haerter, and F. A. Henn, Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression, Neurochemical research, vol.34, issue.9, pp.1584-1593, 2009.

I. L. Bogen, Ø. Risa, K. H. Haug, U. Sonnewald, F. Fonnum et al., Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles, Journal of neurochemistry, vol.105, issue.6, pp.2524-2534, 2008.

D. P. Auer, B. Pütz, E. Kraft, B. Lipinski, J. Schill et al., Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study, Biological psychiatry, vol.47, issue.4, pp.305-313, 2000.

G. F. Mason, A. Anand, G. Sanacora, N. Epperson, K. Haga et al., Different relationships among cortical amino acids in unipolar and bipolar depression, Proceedings of the International Society of Magnetic Resonance, vol.9, pp.557-565, 2001.

G. Hasler, J. W. Van-der-veen, T. Tumonis, N. Meyers, J. Shen et al., Reduced prefrontal glutamate/glutamine and ?-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy, Archives of general psychiatry, vol.64, issue.2, pp.193-200, 2007.
DOI : 10.1001/archpsyc.64.2.193

URL : http://archpsyc.jamanetwork.com/data/journals/psych/11838/yoa60057_193_200.pdf

G. Sanacora, R. Gueorguieva, C. N. Epperson, Y. T. Wu, M. Appel et al., Subtype-specific alterations of ?-aminobutyric acid and glutamatein patients with major depression, Archives of general psychiatry, issue.7, pp.705-713, 2004.

Z. Bhagwagar, M. Wylezinska, P. Jezzard, J. Evans, F. Ashworth et al., Reduction in occipital cortex ?-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects, Biological psychiatry, issue.6, pp.806-812, 2007.
DOI : 10.1016/j.biopsych.2006.08.048

D. Arnone, A. N. Mumuni, S. Jauhar, B. Condon, and J. Cavanagh, Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations, European Neuropsychopharmacology, vol.25, issue.8, pp.1109-1117, 2015.

G. Sanacora, G. F. Mason, D. L. Rothman, K. L. Behar, F. Hyder et al., Reduced cortical ?-aminobutyric acid levels in depressed patients 157 determined by proton magnetic resonance spectroscopy, Archives of general psychiatry, vol.56, issue.11, pp.1043-1047, 1999.

G. Sanacora, G. F. Mason, and J. H. Krystal, Impairment of GABAergic transmission in depression: new insights from neuroimaging studies, Critical Reviews? in Neurobiology, vol.14, issue.1, 2000.

G. Sanacora, G. F. Mason, D. L. Rothman, and J. H. Krystal, Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors, American Journal of Psychiatry, vol.159, issue.4, pp.663-665, 2002.

G. Sanacora, G. F. Mason, D. L. Rothman, F. Hyder, J. J. Ciarcia et al., Increased cortical GABA concentrations in depressed patients receiving ECT, American Journal of Psychiatry, vol.160, issue.3, pp.577-579, 2003.

G. Sanacora, L. R. Fenton, M. K. Fasula, D. L. Rothman, Y. Levin et al., Cortical ?-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy, Biological psychiatry, vol.59, issue.3, pp.284-286, 2006.

Z. Bhagwagar, M. Wylezinska, P. Jezzard, J. Evans, E. Boorman et al., Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients, International Journal of Neuropsychopharmacology, vol.11, issue.2, pp.255-260, 2008.

G. Hasler, A. Neumeister, J. W. Van-der-veen, T. Tumonis, E. E. Bain et al., Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy, Biological psychiatry, vol.58, issue.12, pp.969-973, 2005.

A. Kugaya and G. Sanacora, Beyond monoamines: glutamatergic function in mood disorders, CNS spectrums, vol.10, issue.10, pp.808-819, 2005.

G. Nowak, G. A. Ordway, and I. A. Paul, Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims, Brain research, vol.675, issue.12, pp.157-164, 1995.

P. V. Choudary, M. Molnar, S. J. Evans, H. Tomita, J. Z. Li et al., Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15653-15658, 2005.

S. H. Fatemi, T. D. Folsom, R. J. Rooney, and P. D. Thuras, Expression of GABA A ?2-, ?1-and ?-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder, Translational psychiatry, vol.3, issue.9, p.303, 2013.

T. Gos, K. Günther, H. Bielau, H. Dobrowolny, C. Mawrin et al., Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil, Journal of affective disorders, vol.113, issue.1-2, pp.45-55, 2009.

T. Kishi, S. Matsunaga, and N. Iwata, A meta-analysis of memantine for depression, Journal of Alzheimer's Disease, vol.57, issue.1, pp.113-121, 2017.

D. J. Newport, L. L. Carpenter, W. M. Mcdonald, J. B. Potash, M. Tohen et al., Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression, American Journal of Psychiatry, vol.172, issue.10, pp.950-966, 2015.

J. Lai, A. Moxey, G. Nowak, K. Vashum, K. Bailey et al., The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials, Journal of affective disorders, vol.136, issue.1-2, pp.31-39, 2012.

A. Serefko, A. Szopa, P. Wla?, G. Nowak, M. Radziwo?-zaleska et al., Magnesium in depression, Pharmacological Reports, vol.65, issue.3, pp.547-554, 2013.

S. H. Preskorn, B. Baker, S. Kolluri, F. S. Menniti, M. Krams et al., An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder, Journal of clinical psychopharmacology, vol.28, issue.6, pp.631-637, 2008.

J. G. Reid, M. J. Gitlin, and L. L. Altshuler, Lamotrigine in psychiatric disorders, The Journal of clinical psychiatry, vol.74, issue.7, pp.675-684, 2013.

G. Bartholini, Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry, vol.125, pp.265-269, 1979.

G. Magni, M. Garreau, B. Orofiamma, and R. Palminteri, Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six doubleblind studies versus tricyclics, Neuropsychobiology, vol.20, issue.3, pp.126-131, 1988.

J. A. Gray, J. Mellanby, and C. Buckland, Behavioural studies of the role of GABA in anxiolytic drug action, Neuropharmacology, 1984.

A. Pilc and K. G. Lloyd, Chronic antidepressants and GABA-B? receptors: a GABA hypothesis of antidepressant drug action, Life sciences, vol.35, issue.21, pp.2149-2154, 1984.

A. K. Rose and A. Jones, Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis, 2018.

R. C. Alexander, The potential efficacy of GABAB antagonists in depression. Current opinion in pharmacology, 2017.

S. F. Kendell, J. H. Krystal, and G. Sanacora, GABA and glutamate systems as therapeutic targets in depression and mood disorders, Expert opinion on therapeutic targets, vol.9, issue.1, pp.153-168, 2005.

H. R. Snyder, Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review, Psychological bulletin, vol.139, issue.1, p.81, 2013.

J. Joormann and C. H. Stanton, Examining emotion regulation in depression: a review and future directions, Behaviour Research and Therapy, vol.86, pp.35-49, 2016.

C. G. Kohler, L. J. Hoffman, L. B. Eastman, K. Healey, and P. J. Moberg, Facial emotion perception in depression and bipolar disorder: a quantitative review, Psychiatry research, vol.188, issue.3, pp.303-309, 2011.

G. Serafini, Z. Rihmer, and M. Amore, The role glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior: focus on microglia cells, Neuroimmunol Neuroinflamm, vol.2, issue.2, pp.127-157, 2015.

L. J. Lee, F. S. Lo, and R. S. Erzurumlu, NMDA receptor-dependent regulation of axonal and dendritic branching, Journal of Neuroscience, vol.25, issue.9, pp.2304-2311, 2005.

B. S. Mcewen, N. P. Bowles, J. D. Gray, M. N. Hill, R. G. Hunter et al., Mechanisms of stress in the brain, Nature neuroscience, vol.18, issue.10, p.1353, 2015.

V. Bartanusz, D. Muller, R. C. Gaillard, P. Streit, L. Vutskits et al., Local ?-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus, European Journal of Neuroscience, vol.19, issue.3, pp.777-782, 2004.

K. J. Kovacs, I. H. Miklos, and B. Bali, GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis, Annals of the New York Academy of Sciences, vol.1018, issue.1, pp.466-476, 2004.

N. Nikkheslat, C. M. Pariante, and P. A. Zunszain, Neuroendocrine Abnormalities in Major Depression: An Insight Into Glucocorticoids, Cytokines, and the Kynurenine Pathway, Inflammation and Immunity in Depression, pp.45-60, 2018.

J. M. Gorman and J. P. Docherty, A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders, The Journal of neuropsychiatry and clinical neurosciences, vol.22, issue.3, pp.256-264, 2010.

A. R. Brunoni, M. Lopes, and F. Fregni, A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression, International Journal of Neuropsychopharmacology, vol.11, issue.8, pp.1169-1180, 2008.

P. Vanhoutte and H. Bading, Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation, Current opinion in neurobiology, vol.13, issue.3, pp.366-371, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00079635

C. A. Turner, E. Eren-koçak, E. G. Inui, S. J. Watson, and H. Akil, Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders, Seminars in cell & developmental biology, vol.53, pp.136-143, 2016.

Á. Ciranna, Serotonin as a modulator of glutamate-and GABA-mediated neurotransmission: implications in physiological functions and in pathology, Current neuropharmacology, vol.4, issue.2, pp.101-114, 2006.

N. Müller and M. J. Schwarz, The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression, Molecular psychiatry, vol.12, issue.11, p.988, 2007.

T. Nishikawa and B. Scatton, Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe, Brain Research, vol.279, issue.1-2, pp.325-329, 1983.

V. I. Müller, E. C. Cieslik, I. Serbanescu, A. R. Laird, P. T. Fox et al., Altered brain activity in unipolar depression revisited: meta-analyses of neuroimaging studies, JAMA psychiatry, vol.74, issue.1, pp.47-55, 2017.

V. Krishnan and E. J. Nestler, The molecular neurobiology of depression, Nature, vol.455, issue.7215, p.894, 2008.

M. Het-rot, S. J. Mathew, and D. S. Charney, Neurobiological mechanisms in major depressive disorder, Canadian Medical Association Journal, vol.180, issue.3, pp.305-313, 2009.

U. L. Ziemann, Pharmaco-transcranial magnetic stimulation studies of motor excitability, Handbook of clinical neurology, vol.116, pp.387-397, 2013.
DOI : 10.1016/b978-0-444-53497-2.00032-2

C. Pittenger and R. S. Duman, Stress, depression, and neuroplasticity: a convergence of mechanisms, Neuropsychopharmacology, vol.33, issue.1, p.88, 2008.

E. Frank, R. F. Prien, R. B. Jarrett, M. B. Keller, D. J. Kupfer et al., Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Archives of general psychiatry, vol.48, pp.851-855, 1991.

W. W. Eaton, J. C. Anthony, J. Gallo, G. Cai, A. Tien et al., Natural history of Diagnostic Interview Schedule/DSM-IV major depression: The Baltimore epidemiologic catchment area follow-up, Archives of general psychiatry, vol.54, issue.11, pp.993-999, 1997.
DOI : 10.1001/archpsyc.1997.01830230023003

A. A. Nierenberg, Predictors of response to antidepressants: General principles and clinical implications. Psychiatric Clinics of North America, 2003.
DOI : 10.1016/s0193-953x(02)00105-3

S. Mouchabac, M. Ferreri, F. Cabanac, and M. Bitton, Symptômes résiduels après traitement antidépresseur d'un épisode dépressif majeur: observatoire réalisé en pratique ambulatoire de ville, L'Encéphale, vol.29, issue.5, pp.438-444, 2003.

S. L. Burcusa and W. G. Iacono, Risk for recurrence in depression, Clinical psychology review, vol.27, issue.8, pp.959-985, 2007.

C. H. Kellner, R. M. Greenberg, J. W. Murrough, E. O. Bryson, M. C. Briggs et al., ECT in treatment-resistant depression, American Journal of Psychiatry, vol.169, issue.12, pp.1238-1244, 2012.
DOI : 10.1176/appi.ajp.2012.12050648

K. Hawton, C. C. Comabella, C. Haw, and K. Saunders, Risk factors for suicide in individuals with depression: a systematic review, Journal of affective disorders, vol.147, issue.1-3, pp.17-28, 2013.
DOI : 10.1016/j.jad.2013.01.004

S. Moylan, M. Maes, N. R. Wray, and M. Berk, The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications, Molecular psychiatry, vol.18, issue.5, p.595, 2013.

L. V. Kessing and P. K. Andersen, Evidence for clinical progression of unipolar and bipolar disorders, Acta Psychiatrica Scandinavica, vol.135, issue.1, pp.51-64, 2017.

R. M. Post, Mechanisms of illness progression in the recurrent affective disorders, Neurotoxicity research, vol.18, issue.3-4, pp.256-271, 2010.

L. V. Kessing, Severity of depressive episodes during the course of depressive disorder, The British Journal of Psychiatry, vol.192, issue.4, pp.290-293, 2008.

L. V. Kessing, Course and cognitive outcome in major affective disorder, Danish medical journal, vol.62, issue.11, pp.5160-5160, 2015.

M. Kovacs, S. Obrosky, and C. George, The Course of Major Depressive Disorder from Childhood to Young Adulthood: Recovery and Recurrence in a Longitudinal Observational Study, Journal of Affective Disorders, vol.203, pp.374-381, 2016.

E. Haroon and A. H. Miller, Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders, Neuroprogression in Psychiatric Disorders, vol.31, pp.37-55, 2017.

I. R. Bell, E. E. Hardin, C. M. Baldwin, and G. E. Schwartz, Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities, Environmental research, vol.70, issue.2, pp.84-97, 1995.

I. and R. , T0 LOW-LEVEL CHEMICALS: A NEURAL SENSITIZATION MODEL, Toxicology and Industrial Health, vol.2, issue.425, pp.277-312, 1994.

E. Kraepelin, Manic depressive insanity and paranoia, The Journal of Nervous and Mental Disease, vol.53, issue.4, p.350, 1921.

S. M. Monroe and K. L. Harkness, Life stress, the" kindling" hypothesis, and the recurrence of depression: considerations from a life stress perspective, Psychological review, vol.112, issue.2, p.417, 2005.

D. J. Martino, C. Samamé, E. Marengo, A. Igoa, and S. A. Strejilevich, A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder, Psychiatry Res, vol.235, pp.1-6, 2016.

A. F. Leuchter, I. A. Cook, A. M. Hunter, and A. S. Korb, A new paradigm for the prediction of antidepressant treatment response, Dialogues in clinical neuroscience, vol.11, issue.4, p.435, 2009.

G. Downing, Biomarkers Definitions Working Group. Biomarkers and Surrogate Endpoints, Clinical Pharmacology & Therapeutics, vol.69, pp.89-95, 2001.

M. B. Keller, Remission versus response: the new gold standard of antidepressant care, Journal of Clinical Psychiatry, pp.53-59, 2004.

M. Ansseau, K. Demyttenaere, J. Heyrman, A. Migeotte, S. Leyman et al., Objective: remission of depression in primary care: the OREON Study, European Neuropsychopharmacology, vol.19, issue.3, pp.169-176, 2009.

A. J. Rush, M. Fava, S. R. Wisniewski, P. W. Lavori, M. H. Trivedi et al., Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design, Controlled clinical trials, vol.25, issue.1, pp.119-142, 2004.

A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report, American Journal of Psychiatry, vol.163, issue.11, pp.1905-1917, 2006.

H. A. De-santé, Episode dépressif caractérisé de l'adulte: prise en charge en soins de premier recours, 2017.

L. J. Fochtmann and A. J. Gelenberg, Guideline watch: practice guideline for the treatment of patients with major depressive disorder, Focus, vol.3, issue.1, pp.34-42, 2005.

M. H. Trivedi, A. J. Rush, S. R. Wisniewski, A. A. Nierenberg, D. Warden et al., Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice, American journal of Psychiatry, vol.163, issue.1, pp.28-40, 2006.

M. Sinyor, A. Schaffer, and A. Levitt, The sequenced treatment alternatives to relieve depression (STAR* D) trial: a review, The Canadian Journal of Psychiatry, vol.55, issue.3, pp.126-135, 2010.

M. Olfson, S. C. Marcus, M. Tedeschi, and G. J. Wan, Continuity of antidepressant treatment for adults with depression in the United States, American Journal of psychiatry, vol.163, issue.1, pp.101-108, 2006.

S. M. Stahl and M. M. Grady, Differences in mechanism of action between current and future antidepressants, The Journal of clinical psychiatry, vol.64, pp.13-17, 2003.

M. H. Trivedi, M. Fava, S. R. Wisniewski, M. E. Thase, F. Quitkin et al., Medication augmentation after the failure of SSRIs for depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-1252, 2006.

A. F. Leuchter, L. B. Marangell, K. S. Burgoyne, J. C. Sigl, R. Jain et al., Biomarkers for Rapid Identification of Treatment Effectiveness (BRITE): testing symptoms and biomarkers as predictors of response and remission in MDD, Presented as poster at the Annual Meeting of the American Psychiatric Association, pp.3-8, 2008.

A. F. Leuchter, I. A. Cook, S. P. Hamilton, K. L. Narr, A. Toga et al., Biomarkers to predict antidepressant response, Current psychiatry reports, vol.12, issue.6, pp.553-562, 2010.

A. Szegedi, W. T. Jansen, A. P. Van-willigenburg, E. Van-der-meulen, H. H. Stassen et al., Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients, The Journal of clinical psychiatry, 2009.

A. T. Baker, Non-invasive magnetic stimulation of human motor cortex, Lancet, vol.843, pp.1106-1107, 1985.

T. Kujirai, M. D. Caramia, J. C. Rothwell, B. L. Day, P. D. Thompson et al., Corticocortical inhibition in human motor cortex, The Journal of physiology, vol.471, issue.1, pp.501-519, 1993.

N. Radhu, D. R. De-jesus, L. N. Ravindran, A. Zanjani, P. B. Fitzgerald et al., A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders, Clinical Neurophysiology, vol.124, issue.7, pp.1309-1320, 2013.

W. Klomjai, R. Katz, and A. Lackmy-vallée, Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Annals of physical and rehabilitation medicine, vol.58, pp.208-213, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01202513

D. Lazzaro, V. Ziemann, and U. , The contribution of transcranial magnetic stimulation in the functional evaluation of microcircuits in human motor cortex, Frontiers in neural circuits, vol.7, p.18, 2013.

S. G. Boyd, J. C. Rothwell, J. M. Cowan, P. J. Webb, T. Morley et al., A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities, Neurosurgery & Psychiatry, vol.49, issue.3, pp.251-257, 1986.

D. Lazzaro, V. Oliviero, A. Profice, P. Saturno, E. Pilato et al., Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans, Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, vol.109, issue.5, pp.397-401, 1998.

V. Lazzaro, A. Oliviero, P. Mazzone, A. Insola, F. Pilato et al., Comparison of descending volleys evoked by monophasic and biphasic magnetic stimulation of the motor cortex in conscious humans, Experimental brain research, vol.141, issue.1, pp.121-127, 2001.

D. Lazzaro, V. Ziemann, U. Lemon, and R. N. , State of the art: physiology of transcranial motor cortex stimulation, Brain Stimulation, vol.1, issue.4, pp.345-362, 2008.

R. Salvador, S. Silva, P. J. Basser, and P. C. Miranda, Determining which mechanisms lead to activation in the motor cortex: a modeling study of transcranial magnetic stimulation using realistic stimulus waveforms and sulcal geometry, Clinical neurophysiology, vol.122, issue.4, pp.748-758, 2011.

M. Sommer, A. Alfaro, M. Rummel, S. Speck, N. Lang et al., Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex, Clinical Neurophysiology, vol.117, issue.4, pp.838-844, 2006.

S. Rossi, M. Hallett, P. M. Rossini, and A. Pascual-leone, Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research, Clinical neurophysiology, vol.120, issue.12, pp.2008-2039, 2009.

C. K. Loo, T. F. Mcfarquhar, and P. B. Mitchell, A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression, International Journal of Neuropsychopharmacology, vol.11, issue.1, pp.131-147, 2008.

C. J. Stagg, S. Bestmann, A. O. Constantinescu, L. Moreno-moreno, C. Allman et al., Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex, The Journal of physiology, vol.589, issue.23, pp.5845-5855, 2011.

J. C. Rothwell, M. Hallett, A. Berardelli, A. Eisen, P. Rossini et al., Magnetic stimulation: motor evoked potentials, ElectroencephalogrClinNeurophysiolSuppl, vol.52, pp.97-103, 1999.

L. Kiers, D. Cros, K. H. Chiappa, and J. Fang, Variability of motor potentials evoked by transcranial magnetic stimulation, Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section, vol.89, issue.6, pp.415-423, 1993.

C. W. Hess, K. R. Mills, and N. M. Murray, Measurement of central motor conduction in multiple sclerosis by magnetic brain stimulation, The Lancet, vol.328, issue.8503, pp.355-358, 1986.

P. M. Rossini, D. Burke, R. Chen, L. G. Cohen, Z. Daskalakis et al., Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee, Clinical Neurophysiology, vol.126, issue.6, pp.1071-1107, 2015.

H. Nakamura, H. Kitagawa, Y. Kawaguchi, and H. Tsuji, Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans, The Journal of physiology, vol.498, issue.3, pp.817-823, 1997.

E. Chroni, N. P. Lekka, I. Tsoussis, A. Nikolakopoulou, C. Paschalis et al., Effect of exercise on motor evoked potentials elicited by transcranial magnetic stimulation in psychiatric patients, Journal of clinical neurophysiology, vol.19, issue.3, pp.240-244, 2002.

P. D. Reid, B. Daniels, M. Rybak, Y. Turnier-shea, and S. &pridmore, Cortical excitability of psychiatric disorders: reduced post-exercise facilitation in depression compared to schizophrenia and controls, Australian & New Zealand Journal of Psychiatry, vol.36, issue.5, pp.669-673, 2002.

P. M. Shajahan, M. F. Glabus, P. A. Gooding, P. J. Shah, and K. P. &ebmeier, Reduced cortical excitability in depression. Impaired post-exercise motor facilitation with transcranial magnetic stimulation, The British Journal of Psychiatry, vol.174, issue.5, pp.449-454, 1999.

M. Bajbouj, S. H. Lisanby, U. E. Lang, H. Danker-hopfe, I. Heuser et al., Evidence for impaired cortical inhibition in patients with unipolar major depression, Biological psychiatry, vol.59, issue.5, pp.395-400, 2006.

A. J. Levinson, P. B. Fitzgerald, G. Favalli, D. M. Blumberger, M. Daigle et al., Evidence of cortical inhibitory deficits in major depressive disorder, Biological psychiatry, vol.67, issue.5, pp.458-464, 2010.

J. M. Abarbanel, T. Lemberg, U. Yaroslavski, N. Grisam, and R. H. &belmaker, Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia, Biological psychiatry, vol.40, issue.2, pp.148-150, 1996.

L. Grunhaus, D. Polak, R. Amiaz, and P. N. &dannon, Motor-evoked potential amplitudes elicited by transcranial magnetic stimulation do not differentiate between patients and normal controls, International Journal of Neuropsychopharmacology, vol.6, issue.4, pp.371-378, 2003.

J. P. Lefaucheur, B. Lucas, F. Andraud, J. Y. Hogrel, F. Bellivier et al., Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation, Journal of psychiatric research, vol.42, issue.5, pp.389-398, 2008.

F. Maeda, J. P. Keenan, and A. Leone, Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation, The British Journal of Psychiatry, vol.177, issue.2, pp.169-173, 2000.

K. Menzler, A. Hermsen, K. Balkenhol, C. Duddek, H. Bugiel et al., A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability-A pharmacogenetic transcranial magnetic stimulation study, Epilepsia, vol.55, issue.2, pp.362-369, 2014.

A. Oliviero, P. Profice, P. A. Tonali, F. Pilato, E. Saturno et al., Effects of aging on motor cortex excitability, Neuroscience research, vol.55, issue.1, pp.74-77, 2006.

J. B. Pitcher, K. M. Ogston, and T. S. Miles, Age and sex differences in human motor cortex input-output characteristics, The Journal of physiology, vol.546, issue.2, pp.605-613, 2003.

N. Lang, A. Hasan, E. Sueske, W. Paulus, and M. A. &nitsche, Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study, Neuropsychopharmacology, vol.33, issue.10, p.2517, 2008.

V. Cerqueira, A. De-mendonça, A. Minez, A. R. Dias, and M. Carvalho, Does caffeine modify corticomotor excitability, Neurophysiologie Clinique, vol.36, issue.4, pp.219-226, 2006.

U. Ziemann, S. Lönnecker, and W. Paulus, Inhibition of human motor cortex by ethanol A transcranial magnetic stimulation study, Brain, vol.118, issue.6, pp.1437-1446, 1995.

M. J. Smith, J. C. Keel, B. D. Greenberg, L. F. Adams, P. J. Schmidt et al., Menstrual cycle effects on cortical excitability, Neurology, vol.53, issue.9, pp.2069-2069, 1999.

P. W. Schönle, C. Isenberg, T. A. Crozier, D. Dressler, J. Machetanz et al., Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine, Neuroscience letters, vol.101, issue.3, pp.321-324, 1989.

V. K. Kimiskidis, S. Papagiannopoulos, D. A. Kazis, K. Sotirakoglou, G. Vasiliadis et al., Lorazepam-induced effects on silent period and corticomotor excitability, Experimental brain research, vol.173, issue.4, pp.603-611, 2006.

T. Heidegger, K. Krakow, and U. &ziemann, Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex, European Journal of Neuroscience, vol.32, issue.7, pp.1215-1222, 2010.

M. Inghilleri, A. Berardelli, P. Marchetti, and M. &manfredi, Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans, Experimental Brain Research, vol.109, issue.3, pp.467-472, 1996.

T. V. Ilic, A. Korchounov, and U. &ziemann, Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline, Neuroscience letters, vol.319, issue.2, pp.116-120, 2002.

A. Gerdelat-mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet et al., Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects, Neuroimage, vol.27, issue.2, pp.314-322, 2005.

T. V. Ilic, A. Korchounov, and U. &ziemann, Methylphenidate facilitates and disinhibits the motor cortex in intact humans, Neuroreport, vol.14, issue.5, pp.773-776, 2003.

C. Plewnia, J. Hoppe, C. Hiemke, M. Bartels, L. G. Cohen et al., Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine, Neuroscience letters, vol.330, issue.3, pp.231-234, 2002.

U. Ziemann, S. Lönnecker, B. J. Steinhoff, and W. Paulus, Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study, Annals of neurology, vol.40, issue.3, pp.367-378, 1996.

X. Li, C. C. Tenebäck, Z. Nahas, F. A. Kozel, C. Large et al., Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men, Neuropsychopharmacology, vol.29, issue.7, p.1395, 2004.

V. D. Lazzaro, A. Oliviero, P. Profice, M. A. Pennisi, F. Pilato et al., Ketamine increases human motor cortex excitability to transcranial magnetic stimulation, The Journal of physiology, vol.547, issue.2, pp.485-496, 2003.

T. V. Ili?, F. Meintzschel, U. Cleff, D. Ruge, K. R. Kessler et al., Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity, The Journal of physiology, vol.545, issue.1, pp.153-167, 2002.

D. Lazzaro, V. Oliviero, A. Meglio, M. Cioni, B. Tamburrini et al., Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex, Clinical Neurophysiology, vol.111, issue.5, pp.794-799, 2000.

D. Lazzaro, V. Oliviero, A. Saturno, E. Dileone, M. Pilato et al., Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans, The Journal of physiology, vol.564, issue.2, pp.661-668, 2005.

D. Lazzaro, V. Pilato, F. Dileone, M. Tonali, P. A. &ziemann et al., Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition, The Journal of physiology, vol.569, issue.1, pp.315-323, 2005.

E. Robol, A. Fiaschi, and P. &manganotti, Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study, Journal of the neurological sciences, vol.221, issue.1, pp.41-46, 2004.

M. Bajbouj, E. L. Brakemeier, F. Schubert, U. E. Lang, P. Neu et al., Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder, Experimental neurology, vol.196, issue.2, pp.332-338, 2005.

C. and P. , Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks (KETADEP), 2013.

P. E. Croarkin, P. A. Nakonezny, M. M. Husain, J. D. Port, T. Melton et al., Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine, Brain stimulation, vol.7, issue.2, pp.243-251, 2014.

R. M. Bagby, A. G. Ryder, D. R. Schuller, and M. B. Marshall, The Hamilton Depression Rating Scale: has the gold standard become a lead weight, American Journal of Psychiatry, vol.161, issue.12, pp.2163-2177, 2004.

D. E. Morisky, A. Ang, M. Krousel-wood, and H. J. Ward, Predictive validity of a medication adherence measure in an outpatient setting, The Journal of Clinical Hypertension, vol.10, issue.5, pp.348-354, 2008.

R. R. Mccrae, J. E. Kurtz, S. Yamagata, and A. Terracciano, Internal consistency, retest reliability, and their implications for personality scale validity. Personality and social psychology review, vol.15, pp.28-50, 2011.

I. Greenhouse, S. Noah, R. J. Maddock, and R. B. Ivry, Individual differences in GABA content are reliable but are not uniform across the human cortex, NeuroImage, vol.139, pp.1-7, 2016.

H. D. Brown and S. M. Kosslyn, Cerebral lateralization, Current Opinion in Neurobiology, vol.3, issue.2, pp.183-186, 1993.

R. C. Oldfield, The assessment and analysis of handedness: the Edinburgh inventory, Neuropsychologia, vol.9, issue.1, pp.97-113, 1971.

S. Groppa, A. Oliviero, A. Eisen, A. Quartarone, L. G. Cohen et al., A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee, Clinical Neurophysiology, vol.123, issue.5, pp.858-882, 2012.

M. P. Malcolm, W. J. Triggs, K. E. Light, O. Shechtman, G. Khandekar et al., Reliability of motor cortex transcranial magnetic stimulation in four muscle representations, Clinical neurophysiology, vol.117, issue.5, pp.1037-1046, 2006.

C. Weiss, C. Nettekoven, A. K. Rehme, V. Neuschmelting, A. Eisenbeis et al., Mapping the hand, foot and face representations in the primary motor cortex-retest reliability of neuronavigated TMS versus functional MRI, Neuroimage, vol.66, pp.531-542, 2013.

M. S. George, E. M. Wassermann, W. A. Williams, A. Callahan, T. A. Ketter et al., Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression, Neuroreport: An International Journal for, 1995.

R. Sparing, D. Buelte, I. G. Meister, T. Pau?, and G. R. Fink, Transcranial magnetic stimulation and the challenge of coil placement: a comparison of conventional and stereotaxic neuronavigational strategies, Human brain mapping, vol.29, issue.1, pp.82-96, 2008.

S. Harquel, M. Becu, L. Beynel, A. Chauvin, N. Guyader et al., Cortextool: a signal processing toolbox for cortical excitability by transcranial magnetic stimulation, 2013.

U. Ziemann, C. Zrenner, D. Desideri, and P. Belardinelli, Brain state dependency of corticospinal excitability, Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, vol.10, issue.2, p.382, 2017.

L. G. Krohne, M. G. Safeldt, A. Karabanov, L. Tomasevic, S. Tashiro et al., S146. Does the mean MEP amplitude scale with the phase of pericentral ?-rhythm? A state-informed open-loop EEG-TMS study, Clinical Neurophysiology, p.196, 2018.

W. Van-der-kamp, A. H. Zwinderman, M. D. Ferrari, and J. G. Van-dijk, , 1996.

, Cortical excitability and response variability of transcranial magnetic stimulation, Journal of clinical neurophysiology, vol.13, issue.2, pp.164-171

M. Orth and J. C. Rothwell, The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse, Clinical neurophysiology, vol.115, issue.5, pp.1076-1082, 2004.

F. Maeda, M. Gangitano, M. Thall, and A. Leone, Inter-and intraindividual variability of paired-pulse curves with transcranial magnetic stimulation (TMS), Clinical neurophysiology, vol.113, issue.3, pp.376-382, 2002.

M. Orth, A. H. Snijders, and J. C. Rothwell, The variability of intracortical inhibition and facilitation, Clinical Neurophysiology, vol.114, issue.12, pp.2362-2369, 2003.

C. Otte, S. M. Gold, B. W. Penninx, C. M. Pariante, A. Etkin et al., Major depressive disorder, Nature Reviews Disease Primers, vol.2, p.16065, 2016.